424 related articles for article (PubMed ID: 27413755)
21. Role of urinary podocalyxin in early diagnosis of diabetic nephropathy.
Kostovska I; Trajkovska KT; Cekovska S; Topuzovska S; Kavrakova JB; Spasovski G; Kostovski O; Labudovic D
Rom J Intern Med; 2020 Dec; 58(4):233-241. PubMed ID: 32780718
[No Abstract] [Full Text] [Related]
22. Tubular damage in microalbuminuric patients with primary glomerulonephritis and diabetic nephropathy.
Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM
Ren Fail; 1995 Jan; 17(1):43-9. PubMed ID: 7770643
[TBL] [Abstract][Full Text] [Related]
23. Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy.
Guillén-Gómez E; Bardají-de-Quixano B; Ferrer S; Brotons C; Knepper MA; Carrascal M; Abian J; Mas JM; Calero F; Ballarín JA; Fernández-Llama P
J Diabetes Res; 2018; 2018():6165303. PubMed ID: 29854824
[TBL] [Abstract][Full Text] [Related]
24. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature.
Thipsawat S
Diab Vasc Dis Res; 2021; 18(6):14791641211058856. PubMed ID: 34791910
[TBL] [Abstract][Full Text] [Related]
25. The potential use of urinary transferrin, urinary adiponectin, urinary Retinol Binding Protein, and serum zinc alpha 2 glycoprotein levels as novel biomarkers for early diagnosis of diabetic nephropathy: A case-control study.
Kamel MF; Nassar M; Elbendary A; Mohamed AGA; Abdullah MG; Gomaa HRA; Awad EMI; Mahmoud HH; Elfiki MA; Abdalla NH; Abd Elkareem RM; Soliman AS; Elmessiery RM
Diabetes Metab Syndr; 2022 Apr; 16(4):102473. PubMed ID: 35405355
[TBL] [Abstract][Full Text] [Related]
26. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
[TBL] [Abstract][Full Text] [Related]
27. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES
Nephron; 2015; 131(1):34-42. PubMed ID: 26340089
[TBL] [Abstract][Full Text] [Related]
28. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
Hafez MH; El-Mougy FA; Makar SH; Abd El Shaheed S
Iran J Kidney Dis; 2015 Mar; 9(2):126-31. PubMed ID: 25851291
[TBL] [Abstract][Full Text] [Related]
29. "Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL.
Lacquaniti A; Donato V; Pintaudi B; Di Vieste G; Chirico V; Buemi A; Di Benedetto A; Arena A; Buemi M
Acta Diabetol; 2013 Dec; 50(6):935-42. PubMed ID: 23754672
[TBL] [Abstract][Full Text] [Related]
30. [Early detection of diabetic nephropathy].
Murussi M; Murussi N; Campagnolo N; Silveiro SP
Arq Bras Endocrinol Metabol; 2008 Apr; 52(3):442-51. PubMed ID: 18506269
[TBL] [Abstract][Full Text] [Related]
31. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
Zubiri I; Posada-Ayala M; Sanz-Maroto A; Calvo E; Martin-Lorenzo M; Gonzalez-Calero L; de la Cuesta F; Lopez JA; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
J Proteomics; 2014 Jan; 96():92-102. PubMed ID: 24211404
[TBL] [Abstract][Full Text] [Related]
32. New insights into the use of biomarkers of diabetic nephropathy.
Jha JC; Jandeleit-Dahm KA; Cooper ME
Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
[TBL] [Abstract][Full Text] [Related]
33. Analysis of circulating lncRNA expression profiles in patients with diabetes mellitus and diabetic nephropathy: Differential expression profile of circulating lncRNA
.
Yang Y; Lv X; Fan Q; Wang X; Xu L; Lu X; Chen T
Clin Nephrol; 2019 Jul; 92(1):25-35. PubMed ID: 31079598
[TBL] [Abstract][Full Text] [Related]
34. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
[TBL] [Abstract][Full Text] [Related]
35. Biomarkers of diabetic nephropathy, the present and the future.
Jim B; Santos J; Spath F; Cijiang He J
Curr Diabetes Rev; 2012 Sep; 8(5):317-28. PubMed ID: 22698077
[TBL] [Abstract][Full Text] [Related]
36. Albuminuria and diabetic nephropathy.
Chang SS
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
[TBL] [Abstract][Full Text] [Related]
37. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
[TBL] [Abstract][Full Text] [Related]
38. The association between methylation levels of targeted genes and albuminuria in patients with early diabetic kidney disease.
Aldemir O; Turgut F; Gokce C
Ren Fail; 2017 Nov; 39(1):597-601. PubMed ID: 28805547
[TBL] [Abstract][Full Text] [Related]
39. YKL-40: A biomarker for early nephropathy in type 2 diabetic patients and its association with inflammatory cytokines.
Umapathy D; Dornadula S; Krishnamoorthy E; Mariappanadar V; Viswanathan V; Ramkumar KM
Immunobiology; 2018 Nov; 223(11):718-727. PubMed ID: 30077474
[TBL] [Abstract][Full Text] [Related]
40. Differential proteome profiling using iTRAQ in microalbuminuric and normoalbuminuric type 2 diabetic patients.
Jin J; Ku YH; Kim Y; Kim Y; Kim K; Lee JY; Cho YM; Lee HK; Park KS; Kim Y
Exp Diabetes Res; 2012; 2012():168602. PubMed ID: 22536212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
